Ingrid Scheffer

From Wikipedia, the free encyclopedia

Ingrid Scheffer
Ingrid Scheffer at the Royal Society admissions day in London, July 2018
Ingrid Eileen Scheffer

EducationMethodist Ladies' College, Melbourne
Alma materUniversity of Melbourne (PhD)
AwardsPrime Minister's Prizes for Science (2014)
L'Oréal-UNESCO For Women in Science Award (2012)
Scientific career
InstitutionsFlorey Institute of Neuroscience and Mental Health
ThesisInherited epilepsy syndromes in multiplex families (1988)

Ingrid Eileen Scheffer AO FRS FAA FAHMS[1] is an Australian paediatric neurologist and senior research fellow at the Florey Institute of Neuroscience and Mental Health. She has made several major advances in the field of epilepsy research. Scheffer is credited with finding the first gene implicated in epilepsy. She has also described and classified novel epileptic syndromes such as Epilepsy limited to Females with Mental Retardation.[2]

Early life and education[edit]

Ingrid Eileen Scheffer was born in Melbourne, Victoria on 21 December 1958. She finished her secondary schooling at Methodist Ladies' College in 1976. She attended Monash University, where she graduated with a Bachelor of Medicine and a Bachelor of Surgery (MBBS) in 1983. She went on to complete her PhD in neurology at the University of Melbourne in 1998.

Career and research[edit]

Beyond further describing the aetiology of epilepsy, Ingrid has worked to characterise new epilepsy syndromes, from infancy to adulthood, which have permitted appropriate treatment and diagnosis, such as Dravet Syndrome[3] and Epilepsy limited to Females with Mental Retardation. Her work also provides for more accurate genetic reproductive counselling.

Awards and honours[edit]


  1. ^ a b Anon (2018). "Professor Ingrid Scheffer AO FRS". Royal Society. Retrieved 10 May 2018. One or more of the preceding sentences incorporates text from the website where:

    "All text published under the heading 'Biography' on Fellow profile pages is available under Creative Commons Attribution 4.0 International License.” --Royal Society Terms, conditions and policies at the Wayback Machine (archived 2016-11-11)

  2. ^ Scheffer IE, Turner SJ, Dibbens LM, Bayly MA, Friend K, Hodgson B, Burrows L, Shaw M, Wei C, Ullmann R, Ropers HH, Szepetowski P, Haan E, Mazarib A, Afawi Z, Neufeld MY, Andrews PI, Wallace G, Kivity S, Lev D, Lerman-Sagie T, Derry CP, Korczyn AD, Gecz J, Mulley JC, Berkovic SF (2008). "Epilepsy and mental retardation limited to females: an under-recognized disorder". Brain. 131 (4): 918–927. doi:10.1093/brain/awm338. PMID 18234694.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  3. ^ Jansen FE, Sadleir LG, Harkin LA, Vadlamudi L, McMahon JM, Mulley JC, Scheffer IE, Berkovic SF (2014). "Severe myoclonic epilepsy of infancy (Dravet syndrome): recognition and diagnosis in adults". Neurology. 67 (12): 2224–6. doi:10.1212/01.wnl.0000249312.73155.7d. PMID 17190949. S2CID 31246151.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  4. ^ 14th Annual L’ORÉAL-UNESCO Awards for Women in Science – 2012
  5. ^ 2014 Prime Minister's Prize for Science: The genetics of epilepsy: bringing hope to families
  6. ^ "Fellowship of the Australian Academy of Health and Medical Sciences" (PDF). Australian Academy of Health and Medical Sciences. June 2019. Archived from the original (PDF) on 24 September 2019. Retrieved 12 September 2019.